Contigo Compounding is a compounding pharmacy named by 1 telehealth provider in our database as a source of compounded GLP-1 medication. Everything below is either a provider's statement, a public record we have noted for verification, or our own note; nothing on this page is a finding about the pharmacy's quality.
Facts recorded
- Stated designation: 503A, owned by Eden since August 2025 (Eden announcement) (as described by the providers that name it; 503A/503B status must be confirmed on the FDA's registered outsourcing-facility list and the state board).
- Location: not recorded.
- Formulations providers attribute to it: compounded semaglutide, compounded tirzepatide.
- PCAB accreditation: not checked.
- State licenses: not checked; use the state board lookup for your state.
- Verification status: pending.
Providers that name this pharmacy
- Eden — 503A (Eden-owned Contigo Compounding, acquired August 19, 2025, plus named network partners)
How to verify it before your first dose
- Confirm with your provider, in writing, that this pharmacy will fill your prescription; several providers assign pharmacies by patient and state.
- Look up the pharmacy on your state board of pharmacy's license search (nonresident pharmacies must hold a permit to ship into your state) and on the NABP.
- If the provider describes it as 503B, confirm it appears on the FDA's registered outsourcing-facility list; if 503A, confirm the state license and ask about PCAB accreditation (ACHC directory).
- Ask for a certificate of analysis for your batch showing potency, sterility and endotoxin results, and confirm the active ingredient is the base form of the peptide.
- Search the FDA warning-letter database for the pharmacy's name.
The pharmacy verification guide explains each step and the directory shows the whole provider-to-pharmacy graph.
Frequently asked questions
Which telehealth providers use Contigo Compounding?
Eden name it publicly, per their own pages; assignment can vary by patient and state.
Is Contigo Compounding a 503A or 503B pharmacy?
Providers describe it as 503A, owned by Eden since August 2025 (Eden announcement); confirm on the FDA's 503B list and the state board before relying on it.
Is Contigo Compounding licensed in my state?
Check the state board of pharmacy license search for a nonresident permit; we have not yet recorded state licenses for this pharmacy.